Literature DB >> 7999138

Utilization of geranylgeraniol for protein isoprenylation in C6 glial cells.

D C Crick1, C J Waechter, D A Andres.   

Abstract

When rat C6 glial cells were incubated with [3H]geranylgeraniol (GGol), radioactivity was incorporated into a delipidated protein fraction. SDS-PAGE analysis of the protein fraction labeled by [3H]GGol revealed a 46 kDa polypeptide and a group of labeled polypeptides (19-27 kDa) in the same size range as the small GTP-binding proteins. A similar pattern of labeled polypeptides was seen when C6 cells were metabolically labeled with [14C]mevalonolactone. An isotopically labeled product, chromatographically identical to geranylgeranylcysteine (GG-Cys), was released by Pronase E digestion of the [3H]GGol-labeled protein. When the protein fraction from cells metabolically labeled with [3H]mevalonolactone was digested with Pronase E, two radiolabeled products were released with the chromatographic mobilities of farnesyl-cysteine (F-Cys) and GG-Cys. These studies suggest that C6 glial cells are capable of converting GGol to geranylgeranyl pyrophosphate (GG-P-P), or perhaps a novel "activated" form of the allylic isoprenol, that can be utilized for protein isoprenylation reactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999138     DOI: 10.1006/bbrc.1994.2758

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cells.

Authors:  Susan E Ownby; Raymond J Hohl
Journal:  Lipids       Date:  2002-02       Impact factor: 1.880

2.  Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis.

Authors:  I Campia; C Lussiana; G Pescarmona; D Ghigo; A Bosia; C Riganti
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  Farnesol is utilized for isoprenoid biosynthesis in plant cells via farnesyl pyrophosphate formed by successive monophosphorylation reactions.

Authors:  L Thai; J S Rush; J E Maul; T Devarenne; D L Rodgers; J Chappell; C J Waechter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism.

Authors:  B M Forman; B Ruan; J Chen; G J Schroepfer; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Murine guanylate-binding protein: incomplete geranylgeranyl isoprenoid modification of an interferon-gamma-inducible guanosine triphosphate-binding protein.

Authors:  J T Stickney; J E Buss
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

6.  Protein prenylation in spinach chloroplasts.

Authors:  I Parmryd; B Andersson; G Dallner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice.

Authors:  Gero P Hooff; W Gibson Wood; Ji-Hyun Kim; Urule Igbavboa; Wei-Yi Ong; Walter E Muller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2012-06-13       Impact factor: 5.590

8.  Mutation of 3-hydroxy-3-methylglutaryl CoA synthase I reveals requirements for isoprenoid and cholesterol synthesis in oligodendrocyte migration arrest, axon wrapping, and myelin gene expression.

Authors:  Emily S Mathews; David J Mawdsley; Macie Walker; Jacob H Hines; Marina Pozzoli; Bruce Appel
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

9.  Isoprenoid alcohols restore protein isoprenylation in a time-dependent manner independent of protein synthesis.

Authors:  Susan E Ownby; Raymond J Hohl
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

10.  Farnesyl analogues inhibit vasoconstriction in animal and human arteries.

Authors:  J B Roullet; H Xue; J Chapman; P McDougal; C M Roullet; D A McCarron
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.